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Available online 12 November 2014AbstractAthletic training can result in increased left ventricular (LV) wall thickness, termed physiologic hypertrophy (PhH). By contrast, pathologic
hypertrophy (PaH) can be due to hypertension, aortic stenosis, or genetic mutation causing hypertrophic cardiomyopathy (HCM). Because
morphologic (LV dimension, wall thickness, mass, etc.) and functional index similarities (LV ejection fraction, cardiac output, peak filling rate,
etc.) limit diagnostic specificity, ability to differentiate between PhH and PaH is important. Conventional echocardiographic diastolic function
(DF) indexes have limited ability to differentiate between PhH and PaH and cannot provide information on chamber property (stiffness and
relaxation). We hypothesized that kinematic model-based DF assessment can differentiate between PhH and PaH and, by providing chamber
properties, has even greater value compared with conventional metrics. For validation, we assessed DF in the following three age-matched
groups: pathologic (HCM) hypertrophy (PaH, n ¼ 14), PhH (Olympic rowers, PhH, n ¼ 21), and controls (n ¼ 21). Magnetic resonance
imaging confirmed presence of both types of hypertrophy and determined LV mass and chamber size. Model-based indexes, chamber stiffness
(k), relaxation/viscoelasticity (c), and load (xo) and conventional indexes, Epeak (peak of E-wave), ratio of Epeak to Apeak (E/A), E-wave ac-
celeration time (AT), and E-wave deceleration time (DT) were computed. We analyzed 1588 E waves distributed as follows: 328 (PaH), 672
(athletes), and 588 (controls). Among conventional indexes, Epeak and E-wave DTwere similar between PaH and PhH, whereas E/A and E-wave
AT were lower in PaH. Model-based analysis showed that PaH had significantly higher relaxation/viscoelasticity (c) and chamber stiffness (k)
than PhH. The physiologic equation of motion for filling-based derivation of the model provides a mechanistic understanding of the differences
between PhH and PaH.
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Hypertrophic cardiomyopathy (HCM) is caused by muta-
tion in genes encoding cardiac sarcomere proteins. It is a
common genetic disorder of the cardiovascular system char-
acterized by left ventricular (LV) wall thickening withoutitness. Published by Elsevier (Singapore) Pte Ltd. This is an open access article under the
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atic patients or progressive heart failure.3 HCM is an example
of pathologic hypertrophy (PaH). By contrast, physiologic
hypertrophy (PhH) is induced by exercise, pregnancy, or
normal growth.4,5 Although athletic training can change the
heart morphologically (LV mass, dimension, shape, etc.) and
functionally [LV ejection fraction (LVEF), stroke volume,
peak filling rate, heart rate, etc.], it can be difficult to differ-
entiate PaH from PhH. The ability to differentiate is important,
because undetected HCM is the most frequent cause of sudden
death of athletes during exercise, and misdiagnosis of HCM
can lead to unnecessary disqualification of athletes.6 Electro-
cardiography is unable to differentiate PaH from PhH.7
PaH and PhH manifest differences in cardiac function,
which can be evaluated by echocardiography. Previous studies
have used two-dimensional echocardiography,2 ultrasound
speckle tracking,8 tissue Doppler imaging,9e12 transmitral
flow,13 and M-mode echocardiography14 to show differences
in diastolic function (DF). Transmitral flow analysis has
demonstrated limited value in differentiating between PaH and
PhH.6,14 Common DF indexes, including the ratio of peak
early transmitral flow to peak late atrial filling (E/A), Epeak
(peak E-wave velocity in centimeter/second), E-wave accel-
eration time (AT in milliseconds), and E-wave deceleration
time (DT in milliseconds),15 have provided inconsistent results
regarding DF at rest. Moreover, E-wave parameters are load
dependent and have not been derived from basic physiologic
principles that govern filling.15e21 Indexes (such as E/A) are
generated by the complex interplay of simultaneous physio-
logic determinants and chamber properties. Specifically, E-
wave DT has been shown to explicitly depend on both
chamber stiffness and chamber relaxation/viscoelasticity.22Table 1
Clinical descriptors.
Parameter Controls (n ¼ 21) PhH (n ¼ 21) Pa
Clinical attributes
Age, y 30 ± 5 27 ± 9 3
Height, cm 180 ± 7 182 ± 9 17
Weight, kg 80 ± 12 77 ± 12 8
BSA, m2 2.0 ± 0.2 2.0 ± 0.2 2.
HR, beats/min 67 ± 9 57 ± 11 6
Systolic BP, mmHg 141 ± 13 143 ± 14 13
Diastolic BP, mmHg 85 ± 10 75 ± 13 7
LV dimension and mass-derived indexes
LVEDV, mL 192 ± 25 228 ± 52 18
LVEDV index, mL/m2 a 95 ± 14 115 ± 19 9
LVESV, mL 79 ± 18 93 ± 29 6
LVESV index, mL/m2 a 40 ± 8 47 ± 12 3
LVSV, mL 115 ± 15 134 ± 27 12
LVSV index, mL/m2 a 58 ± 5 68 ± 11 6
LV mass, g 132 ± 20 171 ± 42 22
LV mass index, mL/m2 a 66 ± 8 86 ± 17 11
LVWT, mm 10 ± 1 13 ± 2 2
LVEF, % 59 ± 6 60 ± 5 6
Cardiac output, L/min 7.7 ± 1.5 7.5 ± 1.5 7.
BP ¼ blood pressure; BSA ¼ body surface area; HR ¼ heart rate; LVEDV ¼ lef
LVESV ¼ left ventricular end-systolic volume; LVSV ¼ left ventricular stroke v
hypertrophy; PhH ¼ physiologic hypertrophy.
a These parameters are normalized to BSA. Data are presented as mean ± standTo overcome the limitations of conventional indexes, we
quantified DF using a previously validated mechanistic model
of filling that incorporates the mechanical suction-pump
attribute of the LV. Accordingly, we analyzed E-waves using
the parametrized diastolic filling (PDF) formalism (Appendix
A).23 We have previously characterized PhH of the athlete
heart and compared it with the heart of age-matched controls
in terms of PDF-derived indexes and chamber properties.24 We
found significant differences in stiffness and load between
Olympic athletes and controls. Here, we use our previous work
as a foundation to test the hypothesis that PDF formalism-
derived chamber properties can differentiate PaH from PhH.
By performing serial echocardiographic assessments of DF,
model-based analysis of transmitral flow may elucidate and
characterize the mechanistic changes in HCM compared with
athletes and controls.
MethodsPatient selectionWe analyzed data from 14 HCM patients, 21 athletes, and
21 healthy controls. All three groups were matched for age,
sex, and body surface area (BSA; Table 1). The 14 patients
(average age: 31 years; 11 men) with clinically established
diagnosis of HCM from the cardiomyopathy clinic at Sem-
melweis University Heart Center (Budapest Hungary) were
recruited and screened for magnetic resonance imaging (MRI)
compatibility. Three of the 14 patients were not on any
medication. The classes of medications for the remaining 11
patients were as follows: 10 on beta-blockers, three on
calcium-channel blockers, three on angiotensin-convertingH (n ¼ 14) PhH vs. controls PaH vs. controls PhH vs. PaH
1 ± 14 0.588 0.865 0.350
3 ± 6 0.965 0.019 0.011
4 ± 15 0.830 0.644 0.339
0 ± 0.2 0.898 0.973 0.984
3 ± 7 0.003 0.361 0.200
3 ± 21 0.577 0.665 0.145
8 ± 9 0.034 0.244 0.717
2 ± 34 0.010 0.941 0.006
1 ± 15 <0.001 0.955 <0.001
2 ± 16 0.024 0.343 <0.001
1 ± 7 0.015 0.154 <0.001
0 ± 29 0.039 0.754 0.245
0 ± 13 0.010 0.778 0.089
8 ± 65 0.028 <0.001 0.002
5 ± 31 0.013 <0.001 <0.001
6 ± 5 0.107 <0.001 <0.001
6 ± 7 0.869 0.049 0.011
6 ± 1.6 0.874 0.976 0.967
t ventricular end-diastolic volume; LVEF ¼ left ventricular ejection fraction;
olume; LVWT ¼ left ventricular average wall thickness; PaH ¼ pathologic
ard deviation.
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rhythmic drugs, and one on mineralocorticoids. All the ath-
letes were involved in endurance sport (mainly canoeing). The
controls were healthy individuals who were either university
students or employees, none of whom participated in
competitive sports. All of the participants provided written
informed consent for participation in the study in accordance
with the Medical Research Council Scientific and Ethical
Committee criteria (Semmelweis University).EchocardiographyA complete echocardiographic examination was performed
on all patients in accordance with the American Society of
Echocardiography criteria with a standard clinical imaging
system (Philips iE33; Philips Healthcare, Andover, MA,
USA).25 The wall filter was set at 125 Hz. Two-dimensional
images in apical two- and four-chamber views were obtained.
Pulsed Doppler was used in the apical four-chamber view for
transmitral Doppler with the 4-mm sample volume located at
the leaflet tips and with patients in the left lateral decubitus
position. A standardized method of passive leg elevation in the
recumbent position was used with 0, 45, and 90 foamwedges
to generate physiologic load variation during E-wave recording.Echocardiographic data analysisThe total number of E-waves analyzed conventionally (E-
waves approximated as triangles) and through the PDF
formalism was 1558: 328 from HCM, 672 from athletes, and
588 from controls. Only beats with clear contours were
selected, digitized, and cropped using a custom MATLAB
(MathWorks, Natick, MA, USA) program. The Epeak, E-wave
AT, E-wave DT, peak A-wave velocity, E/A, and heart rates
were computed. The PDF parameters were computed from E-
waves as previously described (Appendix A).26 In brief, the
digitized E-wave image was used to determine the maximum
velocity envelope, from which an automated PDF fit is obtained
using the LevenbergeMarquardt algorithm. The output in-
cludes a measure of goodness of fit and an explicit measurement
of error. Fitting generates three (mathematically unique) PDF
parameters (c, k, and xo) for each E wave (Fig. 1). In addition,Fig. 1. Sequence of operational steps for computing PDF parameters from clinical e
model). The PDF model output consists of the mathematically unique parameters (x
the green contour. MVE ¼ maximum velocity envelope; MSE ¼ mean square errpeak atrioventricular (AV) pressure gradient kxo, maximum
resistive force opposing filling cEpeak, and stored elastic strain
energy before valve opening 1=2kx2o were also computed.Cardiac MRIThe MRI examination (Achieva 1.5T Dual Nova HP
R2.6.3p7, cardiac coil; Philips Healthcare, Andover, MA,
USA) used “breath hold” at end-expiration for each image
acquisition to eliminate respiratory motion artifact. After
obtaining scout images, steady-state free-precession breath-
hold cine images were acquired in four-, three-, and two-
chamber long-axis planes and in sequential 8-mm short-axis
slices (flip angle 60, 0-mm gap) from the AV ring to the
apex. The height and weight of each participant provided the
BSA through the Mosteller formula.27MRI data analysisThe LV end-diastolic volume, LV end-systolic volume, LV
stroke volume, LV mass, and their BSA-normalized values
were computed. The LVaverage (maximal) wall thickness and
LVEF were determined using standard methods. The LV vol-
ume, LVEF, and mass were quantified using planimetry of
end-diastolic and end-systolic short-axis balanced steady-state
free-precession cine images with QMass 7.1 analysis software
(Magnetic Resonance Analytical Software System; Medis
Medical Imaging Systems, Leiden, The Netherlands). Cardiac
output was calculated by multiplying heart rate by stroke
volume. These parameters are listed in Table 1.Statistical analysesConventional and PDF parameters for all E-waves in each
individual were averaged. Mean patient values were used to
calculate group averages (Table 2) and to determine statistical
significance. The MRI data were also averaged for each group
and are reported in Table 1. One-way analysis of variance with
a Tukey post hoc test was performed in SPSS Statistics 22
(IBM, Armonk, NY, USA) to determine whether the parameter
value difference between groups was significant, using
p < 0.05 as the criterion.chocardiographic E-wave contours (blue dots denote MVE used as input to the
o, c, and k) that specify each E wave. The PDF model-predicted fit is shown as
or (see text for details); PDF ¼ parametrized diastolic filling.
Table 2
Transmitral flow measurement.
Parameter Controls (n ¼ 21) PhH (n ¼ 21) PaH (n ¼ 14) PhH vs. controls PaH vs. controls PhH vs. PaH
Conventional Doppler indexes
Epeak, cm/s 78 ± 14 84 ± 16 91 ± 23 0.527 0.095 0.487
E-wave AT, ms 80 ± 6 112 ± 16 75 ± 6 <0.001 0.446 <0.001
E-wave DT, ms 162 ± 23 220 ± 32 203 ± 66 <0.001 0.019 0.421
Edur, ms 279 ± 32 332 ± 42 297 ± 37 <0.001 0.358 0.023
VTI, m 0.108 ± 0.016 0.139 ± 0.028 0.131 ± 0.043 0.028 0.076 0.808
E/A 1.7 ± 0.4 1.9 ± 0.5 1.5 ± 0.4 0.193 0.548 0.030
PDF parameters and indexes computed from them
c, g/s 15.4 ± 2.6 15.0 ± 3.1 19.3 ± 2.9 0.905 <0.001 <0.001
k, g/s2 235 ± 31 188 ± 44 248 ± 45 <0.001 0.619 <0.001
xo, cm 9.3 ± 1.4 11.8 ± 2.5 12.0 ± 4.2 0.011 0.017 0.987
c2e4mk, g2/s2 687 ± 115 492 ± 153 603 ± 194 <0.001 0.253 0.099
1=2kx2o, mJ 1.1 ± 0.4 1.4 ± 0.7 1.9 ± 1.6 0.519 0.028 0.227
kxo, N 21.9 ± 4.8 21.9 ± 6.3 28.9 ± 8.3 0.998 0.007 0.007
cEpeak, N 11.9 ± 3.0 12.6 ± 4.3 17.6 ± 6.1 0.859 <0.001 0.005
M 1.09 ± 0.12 1.08 ± 0.16 1.18 ± 0.11 0.993 0.134 0.109
1=2kx2o ¼ kinetic energy; AT ¼ acceleration time; c ¼ relaxation/viscoelasticity; cEpeak ¼ peak resistive force; DT ¼ deceleration time; E/A ¼ ratio of E-wave
peak to A-wave peak; Edur ¼ duration of E wave; Epeak ¼ peak velocity of E wave; k ¼ chamber stiffness; kxo ¼ peak atrioventricular pressure gradient;M ¼ load-
independent index of diastolic filling; PaH ¼ pathologic hypertrophy; PDF ¼ parametrized diastolic filling; PhH ¼ physiologic hypertrophy; VTI ¼ velocity time
integral, the area under the E-wave; xo ¼ load.
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(n ¼ 56). The sex of the participants is as follows: 11 men/
three women in the HCM group, 18 men/three women ath-
letes, and 19 men/two women in the control group. All athletes
participated in endurance training (canoeing), with 16 of the
21 being elite athletes and the remaining five being master
athletes. Among the elite athletes, 11 were members of the
Hungarian national team, two were Olympic athletes, and
three were world champions. The control group consisted of
healthy university students or university employees, none of
whom participated in competitive sports.
Comparison between the athlete and control groups has
been previously reported by our group.24 The PaH group did
not differ from athletes and controls in age, weight, BSA, heart
rate, cardiac output, and systolic/diastolic blood pressure
(Table 1).
The LV chamber dimensions and mass were determined
from MRI data. The LV cavity size of the HCM group was
significantly lower than athletes but comparable to controls,
except for the BSA-normalized LV volume index at end sys-
tole (Table 1). The stroke volume of the HCM group was
slightly lower than athletes but similar to controls (Table 1);
however, LVEF (66 ± 7%) of the HCM group was signifi-
cantly higher than athletes (60 ± 5%; p ¼ 0.011) and controls
(59 ± 6%; p ¼ 0.049). The HCM group had substantially
higher LV mass (228 ± 65 g) than athletes (171 ± 42 g;
p ¼ 0.002) and controls (132 ± 20 g; p < 0.001). As required
by the criterion for diagnosing HCM (i.e., LV wall
thickness  15 mm), the LV wall thickness of patients in the
HCM group (26 ± 5 mm) was markedly higher than in athletes
(13 ± 2 mm; p < 0.001) and in controls (10 ± 1 mm;p < 0.001). These attributes (dimension, mass, and wall
thickness) confirm the presence of PaH in the HCM group.DF assessment from transmitral flow: conventional and
PDF parametersThe conventional Doppler echocardiographic and PDF
parameters are shown in Table 2. The Epeak in PaH is com-
parable to the other groups. The E/A (1.5 ± 0.4) in PaH is
significantly lower than athletes (1.9 ± 0.5; p ¼ 0.030) but
similar to controls (1.7 ± 0.4; p ¼ 0.548). The Edur in PaH
(297 ± 37 ms) is significantly lower than in athletes
(332 ± 42 ms; p ¼ 0.023) and comparable with controls
(279 ± 32 ms). The PaH group's E-wave DT (203 ± 66 ms) is
comparable with the athlete group but markedly longer than
controls (162 ± 23 ms; p ¼ 0.019). The conventional echo-
cardiographic measurements are in accordance with previous
studies.9,28
The PDF parameter-based comparison revealed distinctive
features of each type of hypertrophy. Fig. 2 shows three
representative E waves, one from each group, along with their
PDF parameters. Compared with controls, both PaH patients
and athletes had substantially elevated but indistinguishable
preloads (xo: 12.0 ± 4.2 cm in PaH; 11.8 ± 2.5 cm in athletes;
and 9.3 ± 1.4 cm in controls). Relaxation/viscoelasticity was
increased only in PaH patients but not in athletes (c:
19.3 ± 2.9 g/s in PaH; 15.0 ± 3.1 g/s in athletes; and
15.4 ± 2.6 g/s in controls). Compared with controls, LV
chamber stiffness was elevated in PaH patients but was
significantly lower in athletes (k: 248 ± 45 g/s2 in PaH;
188 ± 44 g/s2 in athletes; and 235 ± 31 g/s2 in controls). E-
wave area (the velocity time integral or VTI) was comparable
between athletes (0.139 ± 0.03 m) and PaH patients
(0.131 ± 0.04 m) and higher than the control group
(0.108 ± 0.02 m). The peak recoil force (kxo) and peak
Fig. 2. Three E-waves with values of their PDF parameters. (A) Pathologic hypertrophy (HCM); (B) physiologic hypertrophy (rowing athlete); (C) Control.
HCM ¼ hypertrophic cardiomyopathy; PDF ¼ parametrized diastolic filling.
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group than in the other two groups (Table 2). We also calcu-
lated M, the load-independent index of DF.29 We found M to
be similar across the three groups (1.18 ± 0.11 in HCM;
0.108 ± 0.16 in athletes; and 1.09 ± 0.12 in controls).
Discussion
The morphologic similarity between PaH and PhH makes
differentiation difficult. The common clinical diagnostic cri-
terion for PaH is LV wall thickness of 15 mm or more in the
absence of other factors that may cause LV hypertrophy.7
Meanwhile, exercise typically remodels the LV such that its
wall thickness would mildly increase, up to 12 mm.6 This
leaves a “gray zone” where the wall thickness falls between 13
and 15 mm, which could be due to either exercise or mild
PaH.6 From a functional perspective, athlete hearts at rest have
similar echocardiographic parameters as control patients.24
When compared with PaH patients, athletes have normal E/
A, whereas PaH patients have abnormal filling and tissue
Doppler patterns.30 However, conventional echocardiographic
parameters are empirical and provide no mechanistic infor-
mation. To overcome this, we used the PDF formalism to
assess DF by analyzing E-waves in athletes, PaH patients, and
controls. We sought to elucidate and characterize differences
in diastolic chamber (kinematic) properties among these
groups. We found that chamber properties were significantly
different between groups. Many previous studies have
analyzed transmitral flow to assess DF using mainly E/A,
which was found to be significantly smaller in PaH patients
than in PhH (athletes).6,13 Moreover, it has been repeatedly
shown that LV relaxation in PaH patients is significantly
delayed.9,31,32Distinguishing power of PDF formalismThe PDF formalism incorporates the suction-pump attribute
of the LV. Filling is modeled by Newton's Second Law in
analogy to the motion of a previously displaced, damped,harmonic oscillator that recoils from rest. Therefore, the ve-
locity is characterized by the following three parameters:
chamber stiffness k, chamber viscoelasticity/relaxation c, and
volumetric preload xo. These parameters uniquely characterize
each E wave in terms of the chamber's physiologic attributes.
Although conventional parameters such as E-wave DT have
been shown to correlate with and be attributed solely to
stiffness,33 more detailed analysis has revealed that E-wave
DT is jointly determined by stiffness and relaxation/visco-
elasticity (k and c) rather than stiffness alone (k).22 Therefore,
PDF analysis allows characterization of DF with greater
specificity. The PDF formalism has been applied in multiple
clinical settings (diabetes, hypertension, heart failure, caloric
restriction) where conventional methods demonstrated limited
utility or were unable to differentiate between groups.34e37Trends in conventional echocardiographic indexesDoppler E- and A-waves were analyzed conventionally, by
approximating waveforms as triangles. We computed Epeak, E-
wave AT and E-wave DT, and E/A in 1588 cycles from the
three groups. We found that both athletes and PaH patients had
longer E-wave DT compared with controls. E-wave duration
was longest in athletes and it was significantly higher than in
PaH patients. Epeak was not significantly different between the
three groups. However, E/A was highest in athletes and was
statistically significantly higher than in PaH patients. The E-
VTI was similar in athletes and PaH patients but it was higher
than controls.
Combined with the LV dimension information in Table 1,
these results indicate that at rest, the athlete heart aspirates a
larger volume per beat than the PaH heart, although the dif-
ference is not statistically significant. Moreover, because the
resting heart rates of athletes are lower than PaH patients
(statistically not significant), the cardiac output of pathologic
and physiologic hypertrophic hearts remains indistinguishable.
Therefore, these conventional echocardiographic flow and
dimension-based indexes are unable to differentiate between
PaH and PhH.
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higher (worse relaxation) in PaH patients than in athletes. The
value of c was also higher in PaH patients than in controls.
Athlete hearts had the lowest stiffness (k) among the three
groups. The stiffness in controls and PaH hearts was compa-
rable. The volumetric preload (xo) was comparable in athletes
and PaH patients and it was significantly higher than in con-
trols. Therefore, the PDF parameters c and k can differentiate
between PaH and PhH.
The initial maximum recoil force (kxo; peak instantaneous
AV pressure gradient analog38) was much higher in PaH than
PhH due to the higher stiffness (k) in these chambers. There-
fore, PaH patients have to generate a greater AV pressure
gradient (proportional to recoil force38) to fill with a volume
similar to that of the athlete heart. The peak resistive force
(cEpeak) was also higher in PaH patients compared with controls
and athletes, indicating a higher resistance (impaired relaxa-
tion) to filling in these hearts. The load-independent index of
DF,M, is a dimensionless parameter defined by the ratio of peak
recoil force to peak resistive force. M was significantly higher
(worse) in PaH patients. This indicates that, for a given increase
in the peak resistive force, the peak recoil force would increase
by a greater amount in PaH patients, indicating a lower filling
efficiency compared with PhH or controls.Physiologic and clinical interpretation of resultsBy analyzing E-waves through the PDF formalism, we
found that diastolic dysfunction in PaH patients is charac-
terized by higher chamber stiffness (higher k) and by delayed
relaxation (higher c). Increased stiffness means that when
filling by the same incremental volume, the pressure increase
(dP/dV) in PaH patients is greater than in PhH. In response to
exercise, which requires increased filling volume, the cham-
ber with PhH can increase its filling volume with a lower
increase in pressure compared with PaH as a result of better
relaxation. A higher value for the relaxation/viscoelasticity
parameter c indicates delayed or incomplete relaxation (re-
sidual diastolic tone) and higher diastolic pressures. In
concordance with results reported from other PaH studies
using invasive methods,32,39,40 increased c and k values
accurately reflect the physiology. According to Gwathmey
et al, the cause of delayed relaxation in PaH is cytosolic Ca2þ
overload.31 Delayed sequestration of Ca2þ into the sarco-
plasmic reticulum implies incomplete crossbridge detach-
ment and increased residual diastolic tone.41 The higher
chamber stiffness in PaH is the combined effect of increased
LV mass, decreased LV chamber volume, and elevated
myocardial stiffness.32
Although the average volumetric preload (xo)da determi-
nant of Epeakdis comparable between the two groups at rest,
meaning that both types of chambers aspirate about the same
amount of blood with each E wave, PaH chambers generate a
much higher peak AV pressure gradient (kxo) than athletes to
achieve it. This provides a mechanistic explanation, notobtainable from conventional E-wave-derived metrics, of how
this form of diastolic dysfunction results in inefficient filling in
PaH. It reinforces the view that diastolic dysfunction can be
viewed as a state of impedance mismatch.42 In addition, the
higher maximum resistive force opposing filling (cEpeak) in
PaH conveys a similar message.LimitationsIn identifying chamber property differences in PhH versus
PaH, we did not further quantify differences among PhH in-
dividuals due to strength training versus endurance training
versus combination training. In addition, the modest sample
size for each group limited our ability to derive definitive
parameter value ranges. While sex-based differences have
been reported, our sample size did not permit us to make any
sex-based conclusions. All of these limitations are mitigated to
an acceptable degree by the large sample of E-waves analyzed
(n ¼ 1588). In addition, because age is a known DF deter-
minant, basing the analysis on three age-matched groups re-
inforces our conclusions. Although some studies found fat-free
mass to be a better scaling factor than BSA in comparing
cardiac dimensions,43,44 due to lack of data on fat-free mass,
BSA was used instead.ConclusionThe morphologic similarities between PhH and PaH can
make echocardiographic differentiation a challenge. Even if
some conventional indexes can differentiate between groups,
their physiologic interpretation remains unclear. To overcome
these limitations, we analyzed DF using conventional and PDF
formalism-derived indexes. Our approach differentiated be-
tween the PaH and PhH and control groups characterized by
MRI and echocardiography, when conventional indexes failed
to do so. Importantly, our method elucidated the group-
differentiating role of stiffness and relaxation as chamber
properties. Because stiffness increases Epeak and impaired
relaxation decreases Epeak, our model-based approach explic-
itly delineates the extent to which stiffness and relaxation are
altered and provides a mechanistic explanation as to why
conventional indexes, Epeak and E-wave DT, are unable to
differentiate between groups.
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The parametrized diastolic filling (PDF) formalism charac-
terizes suction-initiated transmitral flow in analogy to the mo-
tion (kinematics) of a previously displaced, damped, harmonic
oscillator that recoils from rest. This method applies Newton's
Second Law and predicts E-wave (transmitral flow velocity)
contours parametrized in terms of chamber stiffness, relaxation/
viscoelasticity, and load. Accordingly, per unit mass, the recoil
process is governed by Newton's Second Law of motion.
d2x

dt2þ cdxdtþ kx¼ 0 ð1Þ
where c and k represent damping (viscoelasticity/relaxation)
and ventricular stiffness (spring constant), respectively. The
oscillator spring has been displaced by xo (measured in cen-
timeters; the analog of stored elastic strain in the chamber at
end systole) and recoils from rest (initial velocity ¼ 0, cor-
responding to no flow before valve opening). These parameters
(xo, c, and k) are determined directly from the clinical E-wave
contour. Their physiologic interpretation has been extensively
validated using gold-standard (simultaneous micromanometric
hemodynamics and echocardiography) methods that causally
relate these parameters to chamber properties that determine
DF.23,26,45,46 Its applications in physiology include: generation
of the third47 and fourth heart sounds,48 constant-volume
attribute of the four-chambered heart,49 physiologic and clin-
ical significance of mitral annular oscillations or longitudinal
ringing of the ventricle in diastole,50,51 decomposition of E-
wave deceleration time into its stiffness and relaxation com-
ponents,52 and determination of the in-vivo equilibrium vol-
ume of the LV as the volume at diastasis.53
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